Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04921267 · ClinicalTrials.gov registry record · Early Phase 1
Impacts of Training on Effortful Listening
A Early Phase 1 study, sponsored by Kansas State University.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 87
- Enrollment target
NCT04921267: Completed Early Phase 1 study, sponsored by Kansas State University.
NCT04921267 is a Early Phase 1 study that has completed, run by Kansas State University. The registered enrollment target is 87 participants, above the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (64% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04921267, a Early Phase 1 study, has completed, sponsored by Kansas State University.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 87 participants
- Enrollment target
Study Summary
Human listeners will hear speech masked by single-talker speech before and after auditory training.
Primary Outcome
power in the alpha-band
Interventions
- BEHAVIORAL training
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 87 participants |
| Start Date | 2019-10-10 |
| Est. Completion | 2020-05-31 |
| Phase | Early Phase 1 |
What the finished NCT04921267 record still lists
NCT04921267 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 87 participants, a relatively small participant target, above the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (64% higher).
The record links to 0 conditions, and to 1 intervention - of which training is the first listed.
NCT04921267 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04921267 about?
NCT04921267 is a clinical study titled "Impacts of Training on Effortful Listening". Human listeners will hear speech masked by single-talker speech before and after auditory training.
What is the current status of trial NCT04921267?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 87 participants. The study started on 2019-10-10. Estimated completion is 2020-05-31.
What interventions are being tested in trial NCT04921267?
The interventions under investigation include: training (BEHAVIORAL).
Who is sponsoring clinical trial NCT04921267?
This trial is sponsored by Kansas State University, which has 22 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04921267's enrollment target sits among peer trials
87 251st of 2000 higher than 1,746 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03292601 · 87 participants · NA
Brace Monitoring for Adolescent Idiopathic Scoliosis (AIS)
- NCT04291105 · 87 participants · Phase 2
Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients
- NCT04565795 · 87 participants · NA
Safety and Device Performance of the Uriprene® Degradable Temporary Ureteral Stent Following Uncomplicated Ureteroscopy
- NCT05607004 · 87 participants · Phase 2
(Z)-Endoxifen for the Treatment of Premenopausal Women With ER+/HER2- Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI